Kijimoto-Ochiai S, Naiki M, Makita A
Proc Natl Acad Sci U S A. 1977 Dec;74(12):5407-10. doi: 10.1073/pnas.74.12.5407.
We demonstrate that human fibroblasts of the rare Pk phenotype lack globoside, which was identified as the blood group P antigen, and that p cells possess neither globoside nor trihexosyl ceramide, which was identified as Pk antigen. Our investigations indicate also that these glycosphingolipid patterns are most likely caused by inherited preferential biosynthetic pathways in the abnormal phenotypes rather than by excess catabolism of the antigens. Evidence is presented that the fibroblasts of Pk phenotype lack beta-N-acetylgalactosaminyltransferase (globoside synthetase; UDP-N-acetylgalactosamine:trihexosylceramide beta-N-acetylgalactosaminyltransferase; EC 2.4.1.79) activity, and those of p are deficient in alpha-galactosyltransferase (trihexosylceramide synthetase; UDP galactose:lactosylceramide alpha-galactosyltransferase) and possibly also in globoside synthetase. The diminished globoside synthetase activity in p cells, however, is not caused by the defect in the gene coding for this enzyme. It appears, rather, to be caused by a failure in gene expression because one-third of Pk X p hybrids became able to express P antigenicity with a time lag of 3-4 days after cell fusion [Fellous, M., Gerbal, A., Nobillot, G. & Weils, J. (1977) Vox Sang. 32, 262-268].
我们证明,具有罕见Pk表型的人成纤维细胞缺乏被鉴定为血型P抗原的红细胞糖苷脂,而p细胞既不具有红细胞糖苷脂也不具有被鉴定为Pk抗原的三己糖神经酰胺。我们的研究还表明,这些糖鞘脂模式很可能是由异常表型中遗传的优先生物合成途径引起的,而不是由抗原的过度分解代谢引起的。有证据表明,Pk表型的成纤维细胞缺乏β-N-乙酰半乳糖胺基转移酶(红细胞糖苷脂合成酶;UDP-N-乙酰半乳糖胺:三己糖神经酰胺β-N-乙酰半乳糖胺基转移酶;EC 2.4.1.79)活性,而p细胞的α-半乳糖基转移酶(三己糖神经酰胺合成酶;UDP半乳糖:乳糖基神经酰胺α-半乳糖基转移酶)以及可能的红细胞糖苷脂合成酶也有缺陷。然而,p细胞中红细胞糖苷脂合成酶活性的降低并不是由该酶编码基因的缺陷引起的。相反,这似乎是由基因表达失败引起的,因为三分之一的Pk×p杂种在细胞融合后3-4天出现时间滞后,能够表达P抗原性[费卢斯,M.,热尔巴尔,A.,诺比洛,G. & 韦尔斯,J.(1977年)《血液》32,262 - 268]。